Molecular cytogenetic characterization and clinial relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia

Leukemia

Volumn 15, Issue 9, 2001, Pages 1359-1368

  Xu, L ^a   Zhao, W L ^a   Xiong, S M ^a   Su, X Y ^a   Zhao, M ^a   Wang, C ^b   Gao, Y R ^b   Niu, C ^a   Cao, Q ^a   Gu, B W ^a   Zhu, Y M ^a   Gu, J ^a   Hu, J ^a   Yan, H ^a   Shen, Z X ^a   Chen, Z ^a   Chen, S J ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b 1st People's Hosp of Shanghai City   (China)

Author keywords

Acute promyelocytic leukemia; Additional complex chromosome abnormalities; Chromosome painting; Fluorescence in situ hybridization; Translocation

Indexed keywords

ARSENIC TRIOXIDE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RETINOIC ACID; VINCRISTINE;

ACCURACY; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; KARYOTYPE; LEUKEMIA REMISSION; LEUKEMOGENESIS; MALE; MOLECULAR GENETICS; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 17944362262     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402205     Document Type: Article

References (56)

1. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties
2. PML/RAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
3. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice
4. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
5. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
6. Secondary cytogenetic changes in acute promyelocytic leukemia - Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B study
7. Cytogenetic studies in acute promyelocytic leukemia: A survey of secondary chromosomal abnormalities
8. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: Cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C
9. Secondary chromosomal abnormalities in acute leukemias
10. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): A report on 50 patients
11. High frequency of trisomy 8 in acute promyelocytic leukemia: A fluorescence in situ hybridization study
12. Association of t(15;17) and t(8;21) in the initial phase of an acute promyelocytic leukemia
13. t(15;17) in a promyelocytic form of chronic myeloid leukemia blastic crisis
14. Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17)
15. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia
16. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APL) with atypical features
17. A new variant translocation in acute promyelocytic leukaemia: Molecular characterization and clinical correlation
18. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
19. Acute promyelocytic leukemia: From genetics to treatment
20. Biology and treatment of acute promyelocytic leukemia
21. Nonparametric estimation from incomplete observations
22. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction
23. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
24. Non-Hodgkin's lymphomas and myeloid disorders: Deletions associated with t(2;5) and t(3;5) detected by FISH
25. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization
26. Hunting 11q23 deletions with fluorescence in situ hybridization (FISH)
27. B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene
28. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
29. RARA and PML gene rearrangements in acute promyelocytic leukemia with complex translocations and atypical features
30. Molecular analysis of simple variant translocations in acute promyelocytic leukemia
31. Variant complex translocations involving chromosomes 1, 9, 9, 15 and 17 in acute promyelocytic leukemia without RAR alpha/PML gene fusion rearrangement
32. Detection of the PML/RAR alpha fusion gene in acute promyelocytic leukemia with a complex translocation involving chromosomes 15, 17, and 18
33. A new complex translocation (15;20;17) (q22;p13;q21) in acute promyelocytic leukemia
34. Four-chromosomes complex translocations in acute promyelocytic leukemia: Description of two cases
35. A new variant translocation of t(15;17) in a patient with acute promyelocytic leukemia (M3): t(15;19;17) (q22;p13;q12)
36. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia
37. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements
38. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party
39. Differentiation of t(5;17) variant acute promyelocytic leukemia blasts by all-trans retinoic acid
40. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia
41. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
42. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient
43. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
44. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
45. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid
46. Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods
47. White cells
48. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes
49. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
50. Patterns of clonal evolution in transformed chronic myelogenous leukemia
51. A case of acute eosinophilic granulocytic leukemia with PML-RAR alpha fusion gene expression and response to all-trans retinoic acid
52. Basophilic differentiation in acute promyelocytic leukemia
53. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
54. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group
55. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial